Condensed Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,689,062)	$ (4,232,244)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation & amortization	4,471	3,856
Gain on sale of investment		(6,353)
Common stock and warrants issued for services	337,395	320,389
Stock and warrant compensation expense	44,873	59,897
Change in valuation of derivative liability	(174,957)	2,182,790
Debt discount and original issue discount recognized as interest expense	371,073	595,917
Non cash commitment fee expense	51,696
Fair value of re-priced warrants	149,807
(Increase) Decrease in:
Accounts receivable	(25,955)	(22,962)
Prepaid expenses	(138,067)	1,870
Work in progress	(37,438)	(9,797)
Other asset		2,500
Increase (Decrease) in:
Accounts payable	138,787	108,616
Accrued expenses	82,235	(114,375)
Deferred income	82,406	(50,000)
NET CASH USED IN OPERATING ACTIVITIES	(802,736)	(1,159,896)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Proceeds from sale of investment, at cost		6,815
Purchase of fixed assets	(8,301)	(8,685)
CASH USED IN INVESTING ACTIVITIES	(8,301)	(1,870)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible promissory notes	945,000	885,000
Proceeds for issuance of common stock	146,181	450,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,091,181	1,335,000
NET INCREASE IN CASH	280,144	173,234
CASH BEGINNING OF PERIOD	198,384	821,448
CASH END OF PERIOD	478,528	994,682
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	133
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued for supplemental shares	51,697	58,448
Common stock issued for conversion of debt	400,607	786,902
Beneficial conversion feature on convertible note
Fair value of derivative issued		$ 656,756